## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -0.5% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($134.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Globe Life Inc. (NYSE:GL) Is Favoured by Institutional Owners Who Hold 85% of the Company**
- Source: 富途牛牛 | 20260105T160826 | Somewhat-Bullish | Relevance: 100%
- Institutional investors own 85% of Globe Life Inc. (NYSE:GL), indicating strong confidence in the company, though this also means the stock price could be significantly influenced by their collective trading decisions. The Vanguard Group, Inc. is the largest shareholder with 13%, and the top 17 shareholders collectively own 50% of the company. Insiders hold a small stake, under 1%, worth about US$76 million.

**2. Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Investors to Inquire about Securities Investigation**
- Source: ACCESS Newswire | 20260105T083336 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL) securities who purchased them prior to May 8, 2019, and still hold them. The investigation concerns whether Globe Life and certain officers/directors engaged in corporate wrongdoing. Investors are encouraged to contact the law firm to assist with the investigation at no cost to them.

**3. Globe Life (NYSE:GL) Lowered to In-Line Rating by Evercore ISI**
- Source: MarketBeat | 20260106T140718 | Somewhat-Bearish | Relevance: 100%
- Evercore ISI has downgraded Globe Life (NYSE:GL) from an "outperform" to an "in-line" rating, setting a $155.00 price target, suggesting a potential 10.31% upside. Other analysts maintain a generally positive outlook with an average "Moderate Buy" rating and average target price of $166.22. The company recently reported strong Q3 earnings, surpassing consensus estimates, and provided positive guidance for FY 2025 and FY 2026.

**4. CWA Asset Management Group LLC Sells 18,209 Shares of Globe Life Inc. $GL**
- Source: MarketBeat | 20260106T094122 | Somewhat-Bullish | Relevance: 95%
- CWA Asset Management Group LLC has reduced its stake in Globe Life Inc. (NYSE:GL) by 37.5%, selling 18,209 shares in Q3 and leaving it with 30,400 shares valued at approximately $4.35 million. This follows news that Globe Life CEO Frank M. Svoboda also sold 9,379 shares in December, decreasing his ownership by over 20%. Despite these sales, Globe Life reported strong Q3 EPS that beat estimates and set optimistic FY2026 guidance.

**5. Globe Life Inc. Is Going Viral – But Is This Insurance Stock a Secret Cheat Code or a Walking Red Flag?**
- Source: AD HOC NEWS | 20260106T071323 | Neutral | Relevance: 95%
- Globe Life Inc. is gaining traction on social media and in the stock market, raising questions about whether it's a solid investment or an overhyped "boomer stock." The article explores Globe Life's business model, its reputation, and stock performance, positioning it as a potential value play for long-term investors despite mixed online reviews regarding its customer service and sales tactics. It advises investors to conduct thorough research before committing, highlighting the company's focus on life and supplemental health insurance for middle-income families.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | TD Cowen | $199 | $182 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | TD Cowen | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 4 ($1.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 9.3x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (1 raises, avg +9%, $188 target (+35%)). Insider selling cluster ($1.3M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.3B |
| Beta | 0.48 |
| 52W Range | $109.38 - $147.83 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 9.3 |
| Current P/E | 9.6 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.5% to -0.5% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.50% (CS: 33) | Neutral |
| RSI_14 | 54.0 | Neutral |
| MACD Histogram | -0.28 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.066x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $139.69
- **Stop Loss:** $134.27 (3.9% risk)
- **Target:** $145.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 243
- **Position Value:** $33,944.67
- **Portfolio %:** 33.94%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*